GlassScriptPhysician profile
Eunjeong Kim
NPI 1104147834
$50,352.13
in general payments reported to CMS, 2019-2025
22 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,438 · 2020: $27K · 2021: $1,059 · 2022: $7,329 · 2023: $5,015 · 2024: $277 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $3,600 · Food and Beverage: $1,659 · Travel and Lodging: $297.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $3,600.00 |
| Food and Beverage | $1,659.12 |
| Travel and Lodging | $297.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $30,447.66 | 2019-2020 | |
| Medical Device Business Services, INC. | $7,261.87 | 2019-2023 | Carto 3 |
| Abbott Laboratories | $6,132.68 | 2019-2023 | Ensite Precision, Jot Dx, Assurity |
| Boston Scientific Corporation | $3,230.01 | 2019-2024 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Biosense Webster, INC. | $1,278.24 | 2021-2025 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Medtronic, INC. | $409.47 | 2021-2023 | Na |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $316.83 | 2020-2024 | Lifevest |
| Pfizer INC. | $163.33 | 2022-2023 | |
| Biotronik INC. | $160.21 | 2021 | |
| Novartis Pharmaceuticals Corporation | $146.78 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $146.77 | 2021-2024 | Xarelto |
| Atricure, INC. | $135.56 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Alnylam Pharmaceuticals INC. | $98.78 | 2022 | |
| Esperion Therapeutics, INC. | $94.79 | 2021 | |
| Baxter Healthcare | $81.52 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bardy Diagnostics, INC. | $80.78 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.94 | 2022-2023 | Jardiance |
| Edwards Lifesciences Corporation | $38.56 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Amgen INC. | $35.26 | 2024 | Repatha |
| Kiniksa Pharmaceuticals, LTD. | $20.26 | 2022 | |
| Impulse Dynamics (USA) INC. | $19.32 | 2022 | |
| Terumo Medical Corporation | $14.51 | 2023 | Azur Cx Detachable |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eunjeong Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.